Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
Radionuclides that emit alpha particles (charged helium nuclei) are currently used clinically to treat cancers including prostate cancer. Here, the authors combine a humanized antibody to an alpha particle emitter, specifically to target a downstream effector of the androgen receptor and create a fe...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/02a356c6cc14425c8da1a1e7764743bc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:02a356c6cc14425c8da1a1e7764743bc |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:02a356c6cc14425c8da1a1e7764743bc2021-12-02T16:50:08ZFeed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer10.1038/s41467-018-04107-w2041-1723https://doaj.org/article/02a356c6cc14425c8da1a1e7764743bc2018-04-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-04107-whttps://doaj.org/toc/2041-1723Radionuclides that emit alpha particles (charged helium nuclei) are currently used clinically to treat cancers including prostate cancer. Here, the authors combine a humanized antibody to an alpha particle emitter, specifically to target a downstream effector of the androgen receptor and create a feed forward loop that increases the therapeutic efficacy.Michael R. McDevittDaniel L. J. ThorekTakeshi HashimotoTatsuo GondoDarren R. VeachSai Kiran SharmaTeja Muralidhar KalidindiDiane S. AbouPhilip A. WatsonBradley J. BeattieOskar Vilhemsson TimmermandSven-Erik StrandJason S. LewisPeter T. ScardinoHoward I. ScherHans LiljaSteven M. LarsonDavid UlmertNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-11 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Michael R. McDevitt Daniel L. J. Thorek Takeshi Hashimoto Tatsuo Gondo Darren R. Veach Sai Kiran Sharma Teja Muralidhar Kalidindi Diane S. Abou Philip A. Watson Bradley J. Beattie Oskar Vilhemsson Timmermand Sven-Erik Strand Jason S. Lewis Peter T. Scardino Howard I. Scher Hans Lilja Steven M. Larson David Ulmert Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer |
description |
Radionuclides that emit alpha particles (charged helium nuclei) are currently used clinically to treat cancers including prostate cancer. Here, the authors combine a humanized antibody to an alpha particle emitter, specifically to target a downstream effector of the androgen receptor and create a feed forward loop that increases the therapeutic efficacy. |
format |
article |
author |
Michael R. McDevitt Daniel L. J. Thorek Takeshi Hashimoto Tatsuo Gondo Darren R. Veach Sai Kiran Sharma Teja Muralidhar Kalidindi Diane S. Abou Philip A. Watson Bradley J. Beattie Oskar Vilhemsson Timmermand Sven-Erik Strand Jason S. Lewis Peter T. Scardino Howard I. Scher Hans Lilja Steven M. Larson David Ulmert |
author_facet |
Michael R. McDevitt Daniel L. J. Thorek Takeshi Hashimoto Tatsuo Gondo Darren R. Veach Sai Kiran Sharma Teja Muralidhar Kalidindi Diane S. Abou Philip A. Watson Bradley J. Beattie Oskar Vilhemsson Timmermand Sven-Erik Strand Jason S. Lewis Peter T. Scardino Howard I. Scher Hans Lilja Steven M. Larson David Ulmert |
author_sort |
Michael R. McDevitt |
title |
Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer |
title_short |
Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer |
title_full |
Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer |
title_fullStr |
Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer |
title_full_unstemmed |
Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer |
title_sort |
feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/02a356c6cc14425c8da1a1e7764743bc |
work_keys_str_mv |
AT michaelrmcdevitt feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer AT danielljthorek feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer AT takeshihashimoto feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer AT tatsuogondo feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer AT darrenrveach feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer AT saikiransharma feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer AT tejamuralidharkalidindi feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer AT dianesabou feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer AT philipawatson feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer AT bradleyjbeattie feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer AT oskarvilhemssontimmermand feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer AT svenerikstrand feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer AT jasonslewis feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer AT petertscardino feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer AT howardischer feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer AT hanslilja feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer AT stevenmlarson feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer AT davidulmert feedforwardalphaparticleradiotherapyablatesandrogenreceptoraddictedprostatecancer |
_version_ |
1718383077302992896 |